DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) rallied 3.25% to $143.44 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.
This was the stock's sixth consecutive day of gains.
Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company reached on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 3.33% to $271.11, Pfizer Inc. $(PFE)$ rose 1.41% to $27.25, and Abbott Laboratories $(ABT)$ rose 2.09% to $112.68.
Trading volume (5.8 M) remained 1.9 million below its 50-day average volume of 7.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.
Comments